Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Research & Development

Content :

Research & Development

January 21, 2013

Our Research & Development (R&D) strategy focuses on the innovations and technologies that enable us to respond to patients' unmet medical needs. We have a rich development portfolio of projects, which include innovative medicines, biotechnology products or vaccines.

 

Operating through acquisitions, partnerships and close scientific collaboration with academia and research institutions, Sanofi explores new research methodologies such as biotechnologies, nanotechnologies and biomarkers to identify projects that may lead to discovering potentially valuable new medicines in our priority disease areas: diabetes, oncology, opthalamology, infectious diseases, elderly patients and ageing, immuno-inflammation, fibrosis and tissue repair.

Our objective is to develop products tailored to the specific needs of patients in different parts of the world.  Taking a holistic approach to patient care, we work to extend our product range to treat all stages of a disease, from prevention to various stages of treatment.  This also supports pharmacological approaches by developing services and technologies to boost the efficacy of treatment and enhance patients' quality of life.

Of the 65 projects we currently have in our research and development, 17 are in Phase III or have been submitted for approval.

Module :

Corporate Information

Corporate Information

 

QiC Awards

Sanofi hosts QiC Programme Awards

An innovative partnership to promote best practice in healthcare for diabetes patients